It’s Professor Antonio Gasbarrini the new dean of the Faculty of Medicine and Surgery of the Catholic University of the Sacred Heart for the four-year period 2023/24 – 2027/28. Ordinary of Internal Medicine, he was elected dean by the faculty council in the meeting of 6 July 2022 and will take office on 1 November 2022. He succeeds Professor Rocco Bellantone, dean of the faculty from 2010 to 2022. The rector Franco Anelli, a name of the entire university community, congratulated Professor Gasbarrini on his new post, expressing his warmest wishes for a good job.
He curriculum
Gasbarrini, a specialist in internal medicine and in gastroenterology and digestive endoscopy, attended the Biochemical lab liver transplantantion department of the University of Pittsburgh, in the USA, from 1990 to 1993 as a clinical and research fellow in gastroenterology.
He is director of the specialization school in Internal Medicine of the Faculty of Medicine and Surgery and director of the Department of Medical and Surgical Sciences and of the Internal Medicine and Gastroenterology operating units and of the Cemad-Digestive Diseases Center of the Gemelli Irccs University Polyclinic Foundation. In addition, he coordinates the integrated course of Medical Clinic and Medical Therapy of the Degree in Medicine and Surgery. Among the numeros ariche he is also a member of the Board of Directors of the Gemelli Irccs University Polyclinic Foundation, a member of the Board of Directors of the European helicobacter and microbiota study group (Ehmsg), of the European association of gastroenterology endoscopy and nutrition (Eagen), of the Scientific Committee of the United European gastroenterology (Ueg), of the Italian Celiac Association (aic) and of the Transdisciplinary research on food issues center (Trofic) of the Catholic University.
Scientific publications
Behind Gasbarrini has over 1240 publications cited on Pubmed. From 2006 to 2008 he was secretary of the Italian liver study association (Aisf) and from 2008 to 2011 president of the Italian research foundation in hepatology (fire), from 2010 to 2015 coordinator of Alliance against hepatitis (Ace), from 2016 to 2021 he was vice president of the Italian Digestive Diseases Foundation.
His fields of interest concern acute and chronic inflammatory and oncological diseases of the gastrointestinal tract, liver and pancreas. In recent years he has developed a particular focus on the role of the intestinal microbiota in the health and pathogenesis of digestive and extradigestive diseases, in the interaction between liver-gut and brain-gut, and on the role that nutrition, probiotics, antibiotics and microbiota transplantation play in modulate it.